{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:13:57Z","timestamp":1774304037080,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004337","name":"St. George's, University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ijcard.2023.04.046","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T12:37:21Z","timestamp":1682512641000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes?"],"prefix":"10.1016","volume":"384","author":[{"given":"Fausto J.","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo F.","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe M.C.","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr","family":"Nedoshivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2023.04.046_bb0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: a \u2018diamond\u2019 approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"ESC scientific document group. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"issue":"Suppl C","key":"10.1016\/j.ijcard.2023.04.046_bb0015","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1093\/eurheartj\/suz035","article-title":"The multifaceted angina","volume":"21","author":"Ferrari","year":"2019","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jacc.2012.04.046","article-title":"Rethinking stable ischemic heart disease: is this the beginning of a new era?","volume":"60","author":"Pepine","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0025","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(21)02045-6","article-title":"What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?","volume":"399","author":"Boden","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0035","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2147\/PPA.S222176","article-title":"Patient perspectives on factors influencing medication adherence among people with coronary heart disease (CHD) and CHD risk factors","volume":"13","author":"Mondesir","year":"2019","journal-title":"Patient Prefer. Adher."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0040","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0045","author":"European Heart Network"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/2047487320912491","article-title":"CICD investigators group. Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: the ESC EORP CICD-LT registry","volume":"28","author":"Komajda","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0055","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"EUROASPIRE investigators. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0060","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","article-title":"COURAGE trial investigators. Effect of PCI on long-term survival in patients with stable ischemic heart disease","volume":"373","author":"Sedlis","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0065","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"ISCHEMIA research group. Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0070","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/eurjpc\/zwab191","article-title":"Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality","volume":"29","author":"Buckley","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0075","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.121.054567","article-title":"CLARIFY investigators. International observational analysis of evolution and outcomes of chronic stable angina: the multinational CLARIFY study","volume":"144","author":"Mesnier","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(15)61283-1","article-title":"Pharmacological and emerging therapies in the treatment of chronic angina","volume":"386","author":"Husted","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0095","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/eurheartj\/ehn478","article-title":"REACH registry investigators. Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry","volume":"29","author":"Mehta","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the impact of medication adherence on long-term cardiovascular outcomes","volume":"68","author":"Bansilal","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0105","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jacc.2020.08.078","article-title":"Evaluation and management of patients with stable angina: beyond the ischemia paradigm: JACC state-of-the-art review","volume":"76","author":"Ferraro","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0110","first-page":"820","article-title":"WHO study on prevention of recurrences of myocardial infarction and StrokE (WHO-PREMISE)","volume":"83","author":"Mendis","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/2047487312444995","article-title":"Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study","volume":"20","author":"Vedin","year":"2013","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0120","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jama.2013.3519","article-title":"PURE investigators. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: the prospective urban rural epidemiology (PURE) study","volume":"309","author":"Teo","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0125","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Prospective urban rural epidemiology (PURE) study investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0130","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE investigators. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/eurjpc\/zwaa144","article-title":"Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry","volume":"29","author":"Vynckier","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0140","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/2047487312447846","article-title":"Factors influencing referral to cardiac rehabilitation and secondary prevention programs: a systematic review","volume":"20","author":"Clark","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-5151(03)00091-4","article-title":"Adherence to long-term therapies: evidence for action","volume":"2","author":"De Geest","year":"2003","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"Ho","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0155","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0160","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/2047487317695628","article-title":"The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis","volume":"24","author":"Du","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"TRANSLATE-ACS study investigators. Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study","volume":"170","author":"Mathews","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0170","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1038\/s41598-020-68915-1","article-title":"Medication adherence and its determinants in patients after myocardial infarction","volume":"10","author":"Pietrzykowski","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjopharm.2011.02.004","article-title":"A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity","volume":"9","author":"Gellad","year":"2011","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0180","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/ggi.12616","article-title":"Systematic review of the barriers affecting medication adherence in older adults","volume":"16","author":"Yap","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-018-0707-0","article-title":"Recent approaches to improve medication adherence in patients with coronary heart disease: progress towards a learning healthcare system","volume":"20","author":"Levy","year":"2018","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0190","article-title":"Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial","volume":"369","author":"Ivers","year":"2020","journal-title":"BMJ."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0195","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10198-020-01158-z","article-title":"Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured disease management program on adherence to guideline-recommended medication, health care expenditures, and survival","volume":"21","author":"Kirsch","year":"2020","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0200","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2147\/PPA.S268499","article-title":"Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions","volume":"14","author":"Elnaem","year":"2020","journal-title":"Patient Prefer. Adher."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0205","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/HJH.0000000000002381","article-title":"Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature","volume":"38","author":"Tsioufis","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","article-title":"Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis","volume":"77","author":"Parati","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0215","first-page":"2473","article-title":"Comprehensive efforts to increase adherence to statin therapy","volume":"38","author":"Vonbank","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0220","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ehjcvp\/pvy028","article-title":"Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review","volume":"4","author":"Vonbank","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0230","first-page":"e133","article-title":"Primary nonadherence to statin therapy: patients\u2019 perceptions","volume":"19","author":"Harrison","year":"2013","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0235","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/1359105309341144","article-title":"Perceptions of exercise among people who have not attended cardiac rehabilitation following myocardial infarction","volume":"14","author":"McCorry","year":"2009","journal-title":"J. Health Psychol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0240","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2014.11.107","article-title":"Cardiac Rehabilitation Section of the European Association for Cardiovascular Prevention & Rehabilitation of the ESC. Challenges in secondary prevention of cardiovascular diseases: a review of the current practice","volume":"180","author":"Piepoli","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-150-3-200902030-00007","article-title":"A reengineered hospital discharge program to decrease rehospitalization: a randomized trial","volume":"150","author":"Jack","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0250","first-page":"CD000011","article-title":"Interventions for enhancing medication adherence","volume":"11","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S2213-8587(15)00480-5","article-title":"Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial","volume":"4","author":"Xavier","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0260","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(19)31949-X","article-title":"A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial","volume":"394","author":"Schwalm","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0265","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.2147\/PPA.S368784","article-title":"A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider","volume":"16","author":"Hamrahian","year":"2022","journal-title":"Patient Prefer. Adher."},{"issue":"36","key":"10.1016\/j.ijcard.2023.04.046_bb0270","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC task Force for the Management of Arterial Hypertension","volume":"2018","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0275","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0280","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s13300-019-0601-y","article-title":"Effectiveness and tolerability of vildagliptin and the single pill combination of vildagliptin and metformin in \u201creal-world\u201d management of type 2 diabetes mellitus: the G-FORCE study","volume":"10","author":"Van Gaal","year":"2019","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40292-020-00370-5","article-title":"Single pill regimen leads to better adherence and clinical outcome in daily practice in patients suffering from hypertension and\/or dyslipidemia: results of a meta-analysis","volume":"27","author":"Weisser","year":"2020","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0290","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1093\/eurjpc\/zwaa160","article-title":"Lipid goal achievements after acute myocardial infarction: the gap between real-life and ESC 2019 guidelines","volume":"29","author":"Cambet","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0295","doi-asserted-by":"crossref","DOI":"10.2174\/1573399817666210910165402","article-title":"Rationality, efficacy, tolerability of empagliflozin plus linagliptin combination for the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials and observational studies","volume":"18","author":"Chenchula","year":"2022","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0305","author":"European Medicines Agency"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0310","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0140-6736(02)09358-3","article-title":"Two decades of progress in preventing vascular disease","volume":"360","author":"Yusuf","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0315","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0320","first-page":"CD009868","article-title":"Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases","volume":"3","author":"Bahiru","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0325","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(21)01827-4","article-title":"Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis","volume":"398","author":"Joseph","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0330","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1007\/s12325-021-01754-2","article-title":"Effectiveness and tolerability of the single-pill combination of bisoprolol and perindopril in patients with arterial hypertension and stable coronary artery disease in daily clinical practice: the STYLE study","volume":"38","author":"Boytsov","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0335","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/heart.87.2.140","article-title":"Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population","volume":"87","author":"Brorsson","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2023.04.046_bb0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40119-019-00145-7","article-title":"Effectiveness and impact on adherence of a new fixed-dose combination of ivabradine and metoprolol in a wide range of stable angina patients in real-life practice","volume":"8","author":"Divchev","year":"2019","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0345","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa2208275","article-title":"SECURE investigators. Polypill strategy in secondary cardiovascular prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.04.046_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.663361","article-title":"Practical decision algorithms for the use of the cardiovascular polypill in secondary prevention in Europe","volume":"8","author":"Grigorian-Shamagian","year":"2021","journal-title":"Front. Cardiovasc. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323006009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323006009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:01:45Z","timestamp":1759093305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323006009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":70,"alternative-id":["S0167527323006009"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.04.046","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}